In the latest trading session,, 0.41 million Guardant Health Inc (NASDAQ:GH) shares changed hands as the company’s beta touched 1.17. With the company’s most recent per share price at $30.79 changing hands around $1.06 or 3.57% at last look, the market valuation stands at $3.80B. GH’s current price is a discount, trading about -20.3% off its 52-week high of $37.04. The share price had its 52-week low at $15.81, which suggests the last value was 48.65% up since then. When we look at Guardant Health Inc’s average trading volume, we note the 10-day average is 2.61 million shares, with the 3-month average coming to 2.10 million.
Analysts gave the Guardant Health Inc (GH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.42. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended GH as a Hold, 13 felt it is a Buy and 0 rated the stock as Underweight. Guardant Health Inc’s EPS for the current quarter is expected to be -0.75.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guardant Health Inc (NASDAQ:GH) trade information
Instantly GH is in green as seen in intraday trades today. With action 21.75%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 13.83%, with the 5-day performance at 21.75% in the green. However, in the 30-day time frame, Guardant Health Inc (NASDAQ:GH) is 42.81% up. Looking at the short shares, we see there were 10.26 million shares sold at short interest cover period of 7.41 days.
The consensus price target for the stock as assigned by Wall Street analysts is 40, meaning bulls need an upside of 23.03% from its recent market value. According to analyst projections, GH’s forecast low is 36 with 125 as the target high. To hit the forecast high, the stock’s price needs a -305.98% plunge from its current level, while the stock would need to soar -16.92% for it to hit the projected low.
Guardant Health Inc (GH) estimates and forecasts
Data shows that the Guardant Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 24.51% over the past 6 months, a 55.37% in annual growth rate that is considerably higher than the industry average of 17.10%. Year-over-year growth is forecast to reach 27.40% up from the last financial year.
Consensus estimates given by 21 financial analysts project the company’s revenue in the current quarter to hit an average of 186.11M. 18 analysts are of the opinion that Guardant Health Inc’s revenue for the current quarter will be 190.93M. The company’s revenue for the corresponding quarters a year ago was 155.05M and 168.49M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 20.00%. The estimates for the next quarter sales put growth at 13.30%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.88%. The 2024 estimates are for Guardant Health Inc earnings to increase by 19.45%, but the outlook for the next 5-year period is at 29.20% per year.
GH Dividends
Guardant Health Inc is expected to release its next quarterly earnings report on 2025-Feb-20.
Guardant Health Inc (NASDAQ:GH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 4.56% of Guardant Health Inc shares while 104.37% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 109.36%. There are 104.37% institutions holding the Guardant Health Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 9.5609% of the shares, roughly 11.64 million GH shares worth $336.07 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 9.2332% or 11.24 million shares worth $324.55 million as of 2024-06-30.
